Fed. Circ. Judge Unsure IP At Heart Of $1.1B Juno Win Is Valid
By Britain Eakin · July 6, 2021, 8:46 PM EDT
The Federal Circuit's chief judge appeared receptive Tuesday to Kite Pharma's argument that a Juno Therapeutics drug patent is too broad to be valid, potentially calling into question Juno's more than...
To view the full article, register now.